Nasal decolonization
Showing 1 - 25 of 3,445
Elective Surgery, High Risk, Prevention of Surgical Site Infections Trial in Zürich (Whole Body and nasal decolonization with
Not yet recruiting
- Elective Surgery
- +3 more
- Whole Body and nasal decolonization with octenidin (Octenisan Set)
- Questionnaire for study participants immediately after the decolonization
-
Zürich, Zurich, SwitzerlandBalgrist University Hospital
Dec 9, 2022
COVID-19, SARS-CoV 2 Trial in Madison (10% Povidone-iodine nasal decolonization swab plus 0.12% CHG oral rinse)
Completed
- COVID-19
- SARS-CoV 2
- 10% Povidone-iodine nasal decolonization swab plus 0.12% CHG oral rinse
-
Madison, WisconsinUniversity of Wisconsin-Madison
Jul 12, 2022
Nasal Decolonization of Staphylococcus Aureus Trial in Uppsala (Vehicle gel, 4 + 4 applications or 4 + 2 applications, LTX-109
Completed
- Nasal Decolonization of Staphylococcus Aureus
- Vehicle gel, 4 + 4 applications or 4 + 2 applications
- +2 more
-
Uppsala, SwedenClinSmart Sweden AB
May 25, 2023
Staphylococcus Aureus Infection Trial in United States (Povidone-Iodine Topical Ointment, Standard Care)
Enrolling by invitation
- Staphylococcus Aureus Infection
- Povidone-Iodine Topical Ointment
- Standard Care
-
Atlanta, Georgia
- +4 more
May 16, 2022
Surgical Site Infection Trial in Orange, Sacramento, San Francisco (4% Chlorhexidine Gluconate, 2% Mupirocin, Soap Without
Not yet recruiting
- Surgical Site Infection
- 4% Chlorhexidine Gluconate
- +3 more
-
Orange, California
- +2 more
Dec 21, 2022
Surgical Site Infection Trial in Iowa City (intranasal povidone-iodine)
Completed
- Surgical Site Infection
- intranasal povidone-iodine
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Jun 10, 2021
Nasal Decolonization of Staphylococcus Aureus Trial in Uppsala (LTX-109 gel, 3% w/w, Placebo)
Completed
- Nasal Decolonization of Staphylococcus Aureus
- LTX-109 gel, 3% w/w
- Placebo
-
Uppsala, SwedenClinSmart Sweden AB
Aug 27, 2021
Therapy, Photodynamic, Renal Insufficiency, Chronic Trial (pdt Photodynamic therapy)
Unknown status
- Therapy, Photodynamic
- Renal Insufficiency, Chronic
- pdt Photodynamic therapy
- (no location specified)
Dec 9, 2019
Staphylococcus Aureus Trial in United States (Arm 1. Routine Care (Mupirocin/CHG), Arm 2. Iodophor/CHG Decolonization)
Active, not recruiting
- Staphylococcus Aureus
- Arm 1. Routine Care (Mupirocin/CHG)
- Arm 2. Iodophor/CHG Decolonization
-
Riverside, California
- +136 more
Mar 15, 2022
Staphylococcus Aureus, Orthopaedic Surgery, Surgical Site Infection Trial in Bern (Chlorhexidine, Lifo-Scrub sol 4%®, 500ml, B.
Completed
- Staphylococcus Aureus
- +3 more
- Chlorhexidine, Lifo-Scrub sol 4%®, 500ml, B. Braun
- BACTROBAN® Nasal ong
-
Bern, SwitzerlandSonnenhofspital, Lindenhofgruppe
Jul 16, 2020
Human Microbiome Trial in Baltimore (Mupirocin calcium ointment, 2%, Topical Chlorhexidine, 4%)
Completed
- Human Microbiome
- Mupirocin calcium ointment, 2%
- Topical Chlorhexidine, 4%
-
Baltimore, MarylandBaltimore VA Medical Center VA Maryland Health Care System, Balt
Apr 10, 2020
Decolonization of Patients Carrying S. Aureus Before Cardiac
Completed
- Staphylococcus Aureus
- decolonization
- compliance questionnaire
-
Saint-Etienne, FranceChu Saint-Etienne
Jan 7, 2022
COVID-19 Respiratory Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Pamplona (Nasal Photodisinfection, Sham
Completed
- COVID-19 Respiratory Infection
- SARS-CoV-2 Acute Respiratory Disease
- Nasal Photodisinfection
- Sham Comparator: Control
-
Pamplona, SpainClinica Universidad de Navarra
Aug 10, 2022
Surgical Site Infections, Nosocomial Infection, Healthcare Associated Infections Trial in Savannah (methylene blue
Recruiting
- Surgical Site Infections
- +2 more
- methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation
-
Savannah, GeorgiaMemorial University Medical Center
Feb 4, 2022
COVID-19, Corona Virus Infection, SARS-CoV 2 Trial in Toronto (Methylene-Blue Photodisinfection)
Completed
- COVID-19
- +2 more
- Methylene-Blue Photodisinfection
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Oct 29, 2021
Healthcare Associated Infection, Nosocomial Infection, Surgical Site Infection Trial in Bothell (Methylene Blue Only,
Completed
- Healthcare Associated Infection
- +2 more
- Methylene Blue Only
- +3 more
-
Bothell, WashingtonOndine Research Laboratories
Mar 21, 2023
Nurse's Role, Surgical Site Infection, Patient Satisfaction Trial in Sabadell
Recruiting
- Nurse's Role
- +2 more
-
Sabadell, Barcelona, SpainCorporació Sanitària Parc Taulí
Dec 14, 2021
Methicillin-resistant Staphylococcus Aureus Trial in United States (Standard-of-Care Education, MRSA Decolonization)
Completed
- Methicillin-resistant Staphylococcus Aureus
- Standard-of-Care Education
- MRSA Decolonization
-
Aliso Viejo, California
- +23 more
Sep 27, 2021
SARS-CoV-2 Acute Respiratory Disease Trial (Povidone Iodine 5% Soln,Top,Kit)
Not yet recruiting
- SARS-CoV-2 Acute Respiratory Disease
- Povidone Iodine 5% Soln,Top,Kit
- (no location specified)
Feb 24, 2023
Surgical Site Infection Trial in United States (povidone-iodine topical ointment)
Recruiting
- Surgical Site Infection
- povidone-iodine topical ointment
-
Atlanta, Georgia
- +5 more
Mar 9, 2023
Surgical Site Infection, Brain Tumor Trial in Istanbul (infection prevention bundle)
Suspended
- Surgical Site Infection
- Brain Tumor
- infection prevention bundle
-
Istanbul, TurkeyDepartment of Neurosurgery, Bakirkoy Research and Training Hospi
Aug 2, 2022
Carbapenem-Resistant Enterobacteriaceae, Vancomycin (Glycopeptide) Resistant Enterococcus (VRE) Trial in Chuncheon, Seoul (fecal
Not yet recruiting
- Carbapenem-Resistant Enterobacteriaceae
- Vancomycin (Glycopeptide) Resistant Enterococcus (VRE)
- fecal microbiota transplantation
-
Chuncheon, Gangwon-do, Korea, Republic of
- +1 more
Aug 18, 2023
MRSA, MRSA Colonization Trial in Hvidovre (Clindamycin, Placebo)
Recruiting
- MRSA
- MRSA Colonization
- Clindamycin
- Placebo
-
Hvidovre, DenmarkHvidovre Hospital
Jan 21, 2022